Results 61 to 70 of about 116,948 (101)
Some of the next articles are maybe not open access.
Molybdenum enzymes and molybdenum cofactor in mycobacteria
Journal of Cellular Biochemistry, 2011When intracelluar pathogens enter the host macrophages where in addition to oxidative and antibiotic mechanisms of antimicrobial activity, nutrients are deprived. Human pathogen Mycobacterium tuberculosis is one of macrophage parasitisms, which can replicate and persist for decades in dormancy state in virulent environments.
Tingyu, Shi, Jianping, Xie
openaire +2 more sources
Diagnosis of molybdenum cofactor deficiency
The Lancet, 1999cardiac death in postmenopausal women on oestrogen replacement therapy. Lancet 1998; 352: 1965–69. 2 Simpkins JW, Green PS, Gridley KE, Singh M, de Fiebre NC, Rajakumar G. Role of estrogen replacement therapy in memory enhancement and the prevention of neuronal loss associated with Alzheimer’s disease. Am J Med 1997; 103: 19S–25S. 3 Best PJ, Berger PB,
W S, Waring, S, Maxwell
openaire +4 more sources
MOLYBDENUM COFACTOR BIOSYNTHESIS AND MOLYBDENUM ENZYMES
Annual Review of Plant Biology, 2006The molybdenum cofactor (Moco) forms the active site of all eukaryotic molybdenum (Mo) enzymes. Moco consists of molybdenum covalently bound to two sulfur atoms of a unique tricyclic pterin moiety referred to as molybdopterin. Moco is synthesized from GTP by an ancient and conserved biosynthetic pathway that can be divided into four steps involving ...
Günter, Schwarz, Ralf R, Mendel
openaire +2 more sources
Ahomocysteinemia in molybdenum cofactor deficiency
Neurology, 1998We report an infant with molybdenum cofactor deficiency (MCD) and a unique clinical presentation of hemiplegia, hypotonia, dystonia, and bilateral basal ganglia changes. Biochemistry revealed absent serum homocysteine, low concentrations of plasma cystine, high levels of urinary S-sulfocysteine and sulfite, and high levels of oxypurines in serum and ...
W D, Graf +4 more
openaire +2 more sources
Biosynthesis and Insertion of the Molybdenum Cofactor
EcoSal Plus, 2008The transition element molybdenum (Mo) is of primordial importance for biological systems, because it is required by enzymes catalyzing key reactions in the global carbon, sulfur, and nitrogen metabolism. To gain biological activity, Mo has to be complexed by a special cofactor.
Axel, Magalon, Ralf R, Mendel
openaire +3 more sources
Molybdenum cofactor biosynthesis and deficiency
Cellular and Molecular Life Sciences, 2005The molybdenum cofactor (Moco) forms the active site of all molybdenum (Mo) enzymes, except nitrogenase. Mo enzymes catalyze important redox reactions in global metabolic cycles. Moco consists of Mo covalently bound to one or two dithiolates attached to a unique tricyclic pterin moiety commonly referred to as molybdopterin (MPT). Moco is synthesized by
openaire +2 more sources
Molybdenum cofactor and human disease
Current Opinion in Chemical Biology, 2016Four molybdenum-dependent enzymes are known in humans, each harboring a pterin-based molybdenum cofactor (Moco) in the active site. They catalyze redox reactions using water as oxygen acceptor or donator. Moco is synthesized by a conserved biosynthetic pathway. Moco deficiency results in a severe inborn error of metabolism causing often early childhood
openaire +2 more sources
Human Molybdenum Cofactor Deficiency
1993Molybdenum cofactor deficiency is an inborn error of metabolism first identified in 1980.1,2 Cofactor deficient patients exhibit combined deficiencies of three molybdoenzymes, sulfite oxidase, xanthine dehydrogenase and aldehyde oxidase, all of which depend on the presence of a tightly bound molybdenum-molybdopterin complex for catalytic activity.
J L, Johnson +2 more
openaire +2 more sources
Genetics of molybdenum cofactor deficiency
Human Genetics, 2000Molybdenum cofactor (MoCo) deficiency leads to a combined deficiency of the molybdoenzymes sulphite oxidase, xanthine dehydrogenase and aldehyde oxidase. Effective therapy is not available for this rare disease, which results in neonatal seizures and other neurological symptoms identical to those of sulphite oxidase deficiency.
openaire +2 more sources
Chemistry and biology of the molybdenum cofactor
Biochemical Society Transactions, 1985All molybdenum-containing enzymes other than nitrogenase carry out either oxidative hydroxylation or reductive dehydroxylation of their substrates as exemplified by the reactions catalyzed by sulfite oxidase and nitrate reductase respectively, shown below. The results of X-ray absorbance fine structure studies on sulfite oxidase, xanthine dehydrogenase
openaire +2 more sources

